Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;304(4):787-802.
doi: 10.1002/ar.24519. Epub 2020 Oct 13.

Granulocyte-colony stimulating factor improves intervertebral disc degeneration in experimental adult male rats: A microscopic and radiological study

Affiliations
Free article

Granulocyte-colony stimulating factor improves intervertebral disc degeneration in experimental adult male rats: A microscopic and radiological study

Islam Omar Abdel Fattah et al. Anat Rec (Hoboken). 2021 Apr.
Free article

Abstract

Intervertebral disc degeneration (IVDD) is a major contributor to low back pain (LBP). Granulocyte-colony stimulating factor (GCSF) is known to mobilize hematopoietic stem cells (HSCs) that may be implicated in intervertebral disc (IVD) regeneration. Rats were divided into the following three groups: (i) control group; (ii) IVDD group-the rats underwent Co5/Co6 and Co7/Co8 IVDD operation; and (iii) GCSF-treated group-the rats received daily GCSF subcutaneous injections starting 6 weeks after the IVDD operation and continued for 5 days. All of the rats were euthanized after 8 weeks, and IVDs were assessed by tail X-ray and histopathological, immunohistochemical, and transmission electron microscopy (TEM) analyses. The X-rays showed disc narrowing in the IVDD group that was significantly widened in the GCSF-treated rats. Histologically, the IVDD group showed disarrangement of the annulus fibrosis lamellae, complete degeneration of the nucleus pulposus, and loss of proteoglycan content. These changes were improved after GCSF treatment. Vertebral endplate thickness and cellularity were significantly decreased with IVDD and significantly increased after GCSF treatment. Stromal cell-derived factor-1α (SDF-1α) immune expression was significantly increased in the IVDD group but decreased in the GCSF-treated group. However, the caspase-3 expression percentage showed no significant difference among the studied groups. TEM showed excessive collagen deposits around the notochordal cells in the IVDD group, which were attenuated in the GCSF-treated group. These results indicate that GCSF improves IVDD and promotes its recovery based on radiological, histological and TEM findings.

Keywords: granulocyte-colony stimulating factor; intervertebral disc degeneration; needle puncture; stromal cell derived factor-1α.

PubMed Disclaimer

References

REFERENCES

    1. Ahmadi, S., Zare, S., Ghanbari, R., Bahrami, S., & Zaroushani, V. (2018). The effect of increased manufacturing rate on risk of low back pain. Journal of Paramedical Sciences, 9(3), 49-56.
    1. Almeida, M., Saragiotto, B., Richards, B., & Maher, C. G. (2018). Primary care management of non-specific low back pain: Key messages from recent clinical guidelines. The Medical Journal of Australia, 208(6), 272-275.
    1. An, Y. H., & Martin, K. L. (2003). Handbook of histology methods for bone and cartilage (1st ed., pp. 217-315). Totowa, New Jersey, USA: Humana Press.
    1. Ang, K. L., Shenje, L. T., Srinivasan, L., & Galiñanes, M. (2006). Repair of the damaged heart by bone marrow cells: From experimental evidence to clinical hope. The Annals of Thoracic Surgery, 82(4), 1549-1558.
    1. Asfour, I., Afify, H., Elkourashy, S., Ayoub, M., Kamal, G., Gamal, M., & Elgohary, G. (2017). CXCR4 (CD184) expression on stem cell harvest and CD34+ cells post-transplant. Hematology/Oncology and Stem Cell Therapy, 10(2), 63-69.

MeSH terms

Substances

LinkOut - more resources